Your browser doesn't support javascript.
loading
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Meijer, Titia G; Nguyen, Luan; Van Hoeck, Arne; Sieuwerts, Anieta M; Verkaik, Nicole S; Ladan, Marjolijn M; Ruigrok-Ritstier, Kirsten; van Deurzen, Carolien H M; van de Werken, Harmen J G; Lips, Esther H; Linn, Sabine C; Memari, Yasin; Davies, Helen; Nik-Zainal, Serena; Kanaar, Roland; Martens, John W M; Cuppen, Edwin; Jager, Agnes; van Gent, Dik C.
Afiliación
  • Meijer TG; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. t.meijer@erasmusmc.nl.
  • Nguyen L; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. t.meijer@erasmusmc.nl.
  • Van Hoeck A; Oncode Institute, Utrecht, The Netherlands. t.meijer@erasmusmc.nl.
  • Sieuwerts AM; Oncode Institute, Utrecht, The Netherlands.
  • Verkaik NS; Department of Molecular Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Ladan MM; Oncode Institute, Utrecht, The Netherlands.
  • Ruigrok-Ritstier K; Department of Molecular Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Deurzen CHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van de Werken HJG; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Lips EH; Oncode Institute, Utrecht, The Netherlands.
  • Linn SC; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Memari Y; Oncode Institute, Utrecht, The Netherlands.
  • Davies H; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Nik-Zainal S; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Kanaar R; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Martens JWM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Cuppen E; Department of Immunology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Jager A; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Gent DC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Oncogene ; 41(26): 3498-3506, 2022 06.
Article en En | MEDLINE | ID: mdl-35662281
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos